Official UK procurement notice
Contract for the supply of Duodote autoinjectors
Authority: Secretary of State for Health and Social Care acting as part of the Crown through UK Health Security Agency (Central government)
What is being bought
Published requirement descriptionA procurement exercise for the provision of Duodote autoinjectors
CPV: Pharmaceutical products
The lotProcurement structure
single lot · no lot value publishedLot #1This procurement exercise is for a contract for the provision of Duodote autoinjectors…Awarded
This procurement exercise is for a contract for the provision of Duodote autoinjectors which are to be held in the emergency planning stockpile to be deployed in certain emergency situations . Deliveries will be required over a period of 4 months from September 2022 through to 31 December 2022. Additional information: The contract value is withheld from publication as the Authority has deemed that its release would be contrary to the public interest.
Procedure terms & legal framework
From the official record · publisher note attached- Procedure method
- Award procedure without prior publication of a call for competition
- Legal basis
- CELEX · 32014L0024 Public Contracts Regulations 2015 (Directive 2014/24/EU)
- Procurement category
- Goods
- Notice status
- Awarded without competition
- Procurement threshold
- Unspecified in notice
- Regulatory regime
- Standard
- Commercial structure
- Stand-alone contract (no framework)
- Competition type
- Direct award (no call for competition)
- GPA / WTO covered
- Yes (GPA)
- Recurring procurement
- Unspecified in notice
- First published
- 29 Sept 2022, 15:53 BST
- Last source update
- 29 Sept 2022, 15:53 BST
- Authority reference
CM/EMP/21/30865- FTS notice number
2022/S 000-027372- Classification (CPV)
- Delivery area
- Official registry OCID
ocds-h6vhtk-037182Find a Tender
- Why no open competition
The works, supplies or services can be provided only by a particular economic operator due to protection of exclusive rights, including intellectual property rights
- Published justification
Duodote autoinjectors are the only products available on the market which have been trialled and established by the ambulance service and Meridian Medical Technologies have exclusive rights to manufacture and supply this product, therefore using the negotiated procedure without prior publication is justified under Regulation 32(2)(b)(iii) PCR 2015 as amended.
Publisher note: The contract(s) is for the benefit of the Authority and NHS bodies along with any other non-NHS bodies which are necessary for the delivery of services or goods to NHS bodies, local authorities, other government departments and their executive agencies or non-departmental public bodies charged with the delivery of healthcare or health related services in the United Kingdom, Crown Dependencies and British Overseas Territories including, without limitation, the National Assembly for Wales, the Northern Ireland Assembly, and Scottish Ministers.
Commercial outcome & contract awards
Published awards, contracts and bid statistics, not a forecast| Awarded to | Value | Date | Status |
|---|---|---|---|
| MERIDIAN MEDICAL TECHNOLOGIES LIMITED | US$1 † | — | Awarded |
Contracts
Contract 027372-2022-1 · MERIDIAN MEDICAL TECHNOLOGIES LIMITED
- Signed
- 9 Sept 2022
- Value
- US$1
- Status
- active
Bid statistics published by the authority
| Bids | SME | VCSE | Valid bid range |
|---|---|---|---|
| 1bids · 1 electronic | 1 | — | — |
Contracting authority & participating public bodies
Dispute resolution & review bodies
- The High CourtReview body
Bidders & participating suppliers
1 commercial party on the notice- Meridian Medical Technologies, LtdAwarded supplier
Official documents & specifications
Official links; attachments are not copiedNo document links were published on the notice.